Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma

J Cook1, S Krishnan, S Ananth

  • 1Department of Surgery, University of Kentucky, Lexington 40536, USA.

Oncogene
|February 18, 1999
PubMed

Insights

Prostate apoptosis-related gene 4 (Par-4) protein levels are significantly decreased in renal cell carcinoma, contributing to cancer progression. Restoring Par-4 sensitizes cancer cells to apoptosis, suggesting therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Prostate apoptosis-related gene 4 (Par-4) is a leucine zipper protein crucial for apoptosis induction.
  • Down-regulation of apoptosis-promoting genes is observed during tumorigenesis.
  • The role of Par-4 in renal cell carcinoma (RCC) pathophysiology is not well understood.

Purpose of the Study:

  • To investigate the expression levels of Par-4 in human renal cell carcinoma.
  • To determine the functional significance of Par-4 in RCC cell lines.
  • To explore the potential of Par-4 as a therapeutic target in RCC.

Main Methods:

  • Western blot analysis to quantify Par-4 protein levels in tumor and normal kidney tissues.
  • Immunohistochemistry to assess Par-4 expression patterns.
  • Transfection of RCC cell lines with Par-4 to restore protein levels.
  • Apoptosis assays (e.g., caspase activation, DNA fragmentation) to evaluate cell death sensitivity.

Main Results:

  • Par-4 protein levels were markedly reduced in human renal cell carcinoma specimens compared to adjacent normal tubular cells.
  • Restoration of Par-4 expression in RCC cell lines re-sensitized them to apoptosis induced by various stimuli.
  • Decreased Par-4 expression correlated with features of malignant transformation.

Conclusions:

  • Reduced expression of Par-4 is a common feature in renal cell carcinoma.
  • Par-4 plays a critical role in mediating apoptosis in kidney cancer cells.
  • Re-establishing Par-4 levels may represent a viable strategy to enhance apoptosis and combat renal cell carcinoma progression.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...